This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Peanut Allergy
and you are
between 4 and 55
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The purpose of this study is to demonstrate the efficacy and safety of AR101 through reduction in clinical reactivity to peanut allergen in peanut-allergic children and adults.

Provided treatments

  • Biological: AR101 powder provided in capsules & sachets
  • Biological: Placebo powder provided in capsules & sachets

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02635776. The sponsor of the trial is Aimmune Therapeutics, Inc. and it is looking for 554 volunteers for the current phase.
Official trial title:
Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)